Effect of inducible nitric oxide synthase on apoptosis in Candida-induced acute lung injury

Biomedical Research

Volumn 29, Issue 5, 2008, Pages 257-266

  Hosogi, Shigekuni ^a   Iwasaki, Yoshinobu ^a   Yamada, Takahiro ^a   Komatani Tamiya, Nobuyo ^a   Hiramatsu, Atsushi ^a   Kohno, Yoshihito ^a   Ueda, Mikio ^a   Arimoto, Taichiro ^a   Marunaka, Yoshinori ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 CHLORO 3 IMINO 5 METHYL 2 AZABICYCLO[4.1.0]HEPTANE; CASPASE 3; FAS LIGAND; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; PROTEIN BAX; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; 3 NITROTYROSINE; 3-NITROTYROSINE; 7 CHLORO 3 IMINO 5 METHYL 2 AZABICYCLO(4.1.0)HEPTANE; 7-CHLORO-3-IMINO-5-METHYL-2-AZABICYCLO(4.1.0)HEPTANE; AMIDINE; DRUG DERIVATIVE; FUSED HETEROCYCLIC RINGS; TYROSINE; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; MALE; MESSENGER RNA SYNTHESIS; MOUSE; NICK END LABELING; NONHUMAN; ANIMAL; BAGG ALBINO MOUSE; CANDIDA; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL RATE;

CANDIDA; CANDIDA ALBICANS; MUS;

ACUTE LUNG INJURY; AMIDINES; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRONCHOALVEOLAR LAVAGE FLUID; CANDIDA; CANDIDIASIS; CASPASE 3; FAS LIGAND PROTEIN; HETEROCYCLIC COMPOUNDS, 2-RING; HUMANS; IN SITU NICK-END LABELING; LUNG; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 58149361812     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.29.257     Document Type: Article

References (30)

1. Bachofen M and Weibel ER (1982) Structual alternations of lung parenchyma in the adult respiratory distress syndrome. Clin chest Med 3, 35-56.
2. Bardales RH, Xie SS, Schaefer RF and Hsu SM (1996) Apoptosis is a major pathway responsible for resolution of type II pneumocytes in acute lung injury. Am J Pathol 149, 845-852.
3. Chung HT, Pae HO, Choi BM, Billiar TR and Kim YM (2001) Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282, 1075-1079.
4. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G and Dunagan WC (1992) Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 15, 414-421.
5. Fujita M, Kuwano K, Kunitake R, Hagimoto N, Miyazaki H, Kaneko Y, Kawasaki M, Maeyama T and Hara N (1998) Endothelial cell apoptosis in lipopolysaccharide-induced lung injuiy in mice. Int Arch Allergy Immunol 117, 202-208.
6. Greene KB, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y and Martin TR (1999) Serial changes in surfactant-associated proteins in lung and serum before and after the onset of ARDS. Am J Respir Crit Care Med 160, 1843-1850.
7. Guinee DJ, Brambilia E, Fleming M, Hayashi T, Rahn M, Koss M, Ferrans V and Travis W (1997) The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am J Pathol 151, 999-1007.
8. Ischiropoulos H, Zhu L and Beckman JS (1992) Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 298, 446-451.
9. Janssen YMW, Soultanakis R, Steece K, Heerdt E, Ravinder J, Singh RJ, Joseph J and Kalyanaraman B (1998) Depletion of nitric oxide causes cell cycle alterations, apoptosis, and oxidative stress in pulmonary cells. Am J Physiol Lung Cell Mol Physiol 275, L1100-L1109.
10. Kitamura Y, Hashimoto S, Mizuta N, Kobayashi A, Kooguchi K, Fujiwara I and Nakajima H (2001) Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury. Am J Respir Crit Care Med 163, 752-769.
11. Koizumi T, Ogasawara H, Yamamato H, Tsushima K, Ruan Z, Jian M, Fujimoto K and Kubo K (2004) Effect of ONO1714, a specific inducible nitric oxide synthase inhibitor, on lung lymph filtration and gas exchange during endotoxemia in unanesthetized sheep. Anesthesiology 101, 59-65.
12. Kristof A, Goldberg P, Laubach VE and Hussain SNA (1998) Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 158, 1883-1889.
13. Li J, Billiar TR, Talanian RV and Kim YM (1997) Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240, 419-424.
14. Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, Chi EY, Jonas M and Martin TR (1999) Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 163, 2217-2225.
15. Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR and Liles WC (2001) Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol 158, 153-161.
16. Mikawa K, Nishina K, Takao Y and Obara H (2003) ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits. Anesth Analg 97, 1751-1755
17. Nagata K, Iwasaki Y, Takemura Y, Harada H, Yokomura I, Fushiki S and Nakagawa M (2003) Effect of inhaled NG-nitro-L-arginine methyl ester on Candida-induced acute lung injury. Chest 124, 2293-2301.
18. Nguyen MH, Peacock JE, Tanner DC, Morris AJ, Nguyen ML, Snydman DR, Wagener MM and Yu VL (1995) Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155, 2429-2435.
19. Nucci M, Colombo AL, Silveira F, Richtmann R, Salomao R, Branchini ML and Spector N (1998) Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 19, 846-850.
20. Ohsugi S, Iwasaki Y, Takemura Y, Nagata K, Harada H, Yokomura I, Hosogi S, Yuba T, Niisato N, Miyazaki H, Matsubara H, Fushiki S and Marunaka Y (2007) An inhaled inducible nitric oxide inhibitor reduces damage of Candida-induced acute lung injury. Biomed Res 28, 91-99.
21. Pheng LH, Francoeur C and Denis M (1995) The involvement of nitric oxide in a mouse model of adult respiratory distress syndrome. Inflammation 19, 599-610.
22. Piazza O, Boccia MC, Iasiello A, Storti MP, Tufano R and Triassi M (2004) Candidemia in intensive care patients. Minerva Anestesiol 70, 63-69.
23. Razavi HM, Wang LF, Weicker S, Rohan M, Law C, McCormack DG and Mehta S (2004) Pulmonary neutrophils infiltration in murine sepsis. Am J Respir Crit Care Med 170, 227-233.
24. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U and Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328, 399-405.
25. Rudkowski CJ, Barreiro E, Harfouche R, Goldberg P, Kishta O, D'Orleans-Juste P, Labonte J, Lesur O and Hussain SNA (2004) Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am J Physiol Lung Cell Mol Physiol 286, 793-800.
26. Takemura Y, Iwasaki Y, Nagata K, Yokomura I, Tando S, Fushiki S and Matsubara H (2005) Influence of depletion of alveolar macrophages on apoptosis in Candida-induced acute lung injury. Exp Lung Res 31, 307-321.
27. Wang LF, Patel M, Razavi HM, Weicker S, Joseph MG, McCormack DG and Mehta S (2002) Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am J Respir Crit Care Med 165, 1634-1639.
28. Weinberger B, Fakhrzadeh L, Heck DE, Laskin JD, Gardner CR and Laskin DL (1998) Inhaled nitric oxide primes lung macrophages to produce reactive oxygen and nitrogen intermediates. Am J Respir Crit Care Med 158, 931-938.
29. Wizemann TM, Gardiner CR, Laskin JD, Quinones S, Durham SK, Goller NL, Ohnishi ST and Laskin DL (1994) Production of nitric oxide and peroxynitrite in the lung during endotoxemia. J Leukoc Biol 56, 759-768.
30. Yokomura I, Iwasaki Y, Nagata K, Nakanishi M, Natsuhara A, Harada H, Kubota Y, Ueda M, Inaba T and Nakagawa M (2001) Role of intercellular adhesion molecule 1 in acute lung injury induced by candidemia. Exp Lung Res 27, 417-431.